Tamoxifen synergizes with 4-(E)-{(4-hydroxyphenylimino)-methylbenzene, 1,2-diol} and 4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, novel azaresveratrol analogs, in inhibiting the proliferation of breast cancer cells-Reference-Cited by-同舟云学术

Tamoxifen synergizes with 4-(E)-{(4-hydroxyphenylimino)-methylbenzene, 1,2-diol} and 4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, novel azaresveratrol analogs, in inhibiting the proliferation of breast cancer cells

Published:2016-06-16 Issue:32 Volume:7 Page:51747-51762
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ronghe Amruta¹,Chatterjee Anwesha¹,Bhat Nimee K.¹,Padhye Subhash²,Bhat Hari K.¹

Affiliation:

1. Division of Pharmacology and Toxicology, School of Pharmacy, University of Missouri-Kansas City, Kansas City, Missouri, USA

2. Interdisciplinary Science and Technology Research Academy, Abeda Inamdar Senior College, Department of Chemistry, University of Pune, Pune, India

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antitumor effects of co-treatment of resveratrol with antitumor drugs in ER- and HER2-positive breast cancer cells are due to induction of apoptosis and modulation of estrogen receptor expression;Breast Cancer;2024-05-23

2. Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in MCF7, T47D and BT483 breast cancer cell lines;PLOS ONE;2024-02-26

3. Mechanism of Resveratrol-Induced Programmed Cell Death and New Drug Discovery against Cancer: A Review;International Journal of Molecular Sciences;2022-11-08

4. The Potential Role of Nutraceuticals as an Adjuvant in Breast Cancer Patients to Prevent Hair Loss Induced by Endocrine Therapy;Nutrients;2020-11-18

5. Resveratrol – A comprehensive review of recent advances in anticancer drug design and development;European Journal of Medicinal Chemistry;2020-08